treatment: be with primaquine initiate hemolytic anemia

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents regimen
Weight: 0.66
, surgery
Weight: 0.62
, protocol
Weight: 0.59
, matter
Weight: 0.58
Siblings gene therapy
Weight: 0.72
, dialysis
Weight: 0.70
, blood transfusion
Weight: 0.70
, aspirin
Weight: 0.67

Related properties

Property Similarity
be with primaquine initiate hemolytic anemia 1.00
be with primaquine initiate 0.90
cause hypocalcemia 0.82
cause hyperkalemia 0.82
be effective on monogenic diseases 0.81
inhibit symptoms of rheumatoid arthritis 0.81
inhibit symptoms of arthritis 0.79
be considered thromboxane inhibitor 0.79
be recommended for cns infection 0.78
be contraindicated in asthma patients 0.78

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.44
Rule weight: 0.66
Evidence weight: 0.85
Similarity weight: 0.78
Evidence: 0.85
Plausible(surgery, be recommended for cns infection) ⋁
Evidence: 0.98
¬ Typical(treatment, be with primaquine initiate hemolytic anemia)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.93
Similarity weight: 0.78
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.85
¬ Plausible(surgery, be recommended for cns infection)

Remarkability exclusitivity betweem a parent and a child

0.34
Rule weight: 0.58
Evidence weight: 0.75
Similarity weight: 0.78
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.56
¬ Remarkable(surgery, be recommended for cns infection)

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.72
Similarity weight: 0.82
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.61
¬ Remarkable(blood transfusion, cause hypocalcemia)
0.08
Rule weight: 0.13
Evidence weight: 0.71
Similarity weight: 0.82
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.65
¬ Remarkable(blood transfusion, cause hyperkalemia)
0.07
Rule weight: 0.13
Evidence weight: 0.67
Similarity weight: 0.81
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.73
¬ Remarkable(aspirin, inhibit symptoms of rheumatoid arthritis)
0.07
Rule weight: 0.13
Evidence weight: 0.63
Similarity weight: 0.81
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)

Remarkability from parent implausibility

0.30
Rule weight: 0.42
Evidence weight: 0.92
Similarity weight: 0.78
Evidence: 0.85
Plausible(surgery, be recommended for cns infection) ⋁
Evidence: 0.45
Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.92
¬ Plausible(treatment, be with primaquine initiate hemolytic anemia)

Remarkability from sibling implausibility

0.48
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.81
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.81
Remarkable(gene therapy, be effective on monogenic diseases) ⋁
Evidence: 0.69
¬ Plausible(gene therapy, be effective on monogenic diseases)
0.48
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.82
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.65
Remarkable(blood transfusion, cause hyperkalemia) ⋁
Evidence: 0.78
¬ Plausible(blood transfusion, cause hyperkalemia)
0.48
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.82
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.61
Remarkable(blood transfusion, cause hypocalcemia) ⋁
Evidence: 0.85
¬ Plausible(blood transfusion, cause hypocalcemia)
0.48
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.81
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.73
Remarkable(aspirin, inhibit symptoms of rheumatoid arthritis) ⋁
Evidence: 0.91
¬ Plausible(aspirin, inhibit symptoms of rheumatoid arthritis)

Salient implies Plausible

0.26
Rule weight: 0.28
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.94
¬ Salient(treatment, be with primaquine initiate hemolytic anemia)

Similarity expansion

0.77
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.90
Evidence: 0.98
Typical(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.33
¬ Typical(treatment, be with primaquine initiate)
0.75
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.90
Evidence: 0.94
Salient(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.53
¬ Salient(treatment, be with primaquine initiate)
0.72
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.83
¬ Plausible(treatment, be with primaquine initiate)
0.48
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.90
Evidence: 0.45
Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.68
¬ Remarkable(treatment, be with primaquine initiate)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.94
Salient(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.98
¬ Typical(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia)

Typical implies Plausible

0.44
Rule weight: 0.48
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.98
¬ Typical(treatment, be with primaquine initiate hemolytic anemia)

Typicality and Rermarkability incompatibility between a parent and a child

0.24
Rule weight: 0.51
Evidence weight: 0.59
Similarity weight: 0.78
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.90
¬ Typical(surgery, be recommended for cns infection)

Typicality and Rermarkability incompatibility between siblings

0.08
Rule weight: 0.14
Evidence weight: 0.72
Similarity weight: 0.81
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.62
¬ Typical(gene therapy, be effective on monogenic diseases)
0.07
Rule weight: 0.14
Evidence weight: 0.63
Similarity weight: 0.82
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.82
¬ Typical(blood transfusion, cause hyperkalemia)
0.07
Rule weight: 0.14
Evidence weight: 0.59
Similarity weight: 0.82
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.90
¬ Typical(blood transfusion, cause hypocalcemia)
0.06
Rule weight: 0.14
Evidence weight: 0.58
Similarity weight: 0.81
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.93
¬ Typical(aspirin, inhibit symptoms of rheumatoid arthritis)

Typicality inheritance from parent to child

0.37
Rule weight: 0.48
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.98
Typical(treatment, be with primaquine initiate hemolytic anemia) ⋁
Evidence: 0.90
¬ Typical(surgery, be recommended for cns infection)